Drugs / β-hydroxybutyrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03657537 | Sep 2018 → Feb 2019 | diabetic ketoacidosis, type 2 diabetes mellitus | Bispebjerg Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | β-hydroxybutyrate | “β-hydroxybutyrate is infused intravenously.” NCT03657537 ↗ |
| Route | Intravenous | “β-hydroxybutyrate is infused intravenously.” NCT03657537 ↗ |